Estée Lauder Announces New Skin Longevity Initiative, The Next Frontier of Beauty
Estée Lauder today announces its new Skin Longevity platform, grounded in 15-years of expertise in pioneering skin longevity research. With a new product innovation powered by cutting-edge age reversal technology, Estée Lauder is leading the new frontier in science-driven luxury skincare.
To reinforce the brand’s authority in skin longevity science, Estée Lauder is announcing the formation of a longevity expert collective across multiple disciplines to educate and empower consumers to rethink how they approach skincare and lifestyle – reframing the conversation from anti-aging to visible age reversal. Estée Lauder also announces its support of the Stanford Center on Longevity and its new Program on Aesthetics & Culture, whose work will include research assessing perceptions on longevity and vitality.
“The Estée Lauder brand has always been at the forefront of breakthrough skin science,” said Justin Boxford, Global Brand President, Estée Lauder. “Longevity is one of the fastest growing movements in the beauty and wellness industries, with multi-generational consumer interest in biohacking and age-reversal practices at an all-time high. Estée Lauder has been pioneering skin longevity research for more than 15 years, and we already have the proven technology to reveal visible age reversal. We see this as a truly pivotal moment for the brand to disrupt the industry, changing what we know about skin aging and reimagining skincare for the future.”
Exclusive and Patented SIRTIVITY-LP™ Technology to Reveal Visible Age Reversal
For nearly two decades, Estée Lauder has been studying the role of sirtuins in skin, garnering 29 patents worldwide and presenting at more than 20 scientific conferences to date. Most recently, Estée Lauder unveiled its latest research in skin longevity science to a global audience at the World Congress of Dermatology, one of the largest and most prestigious international dermatological conferences, held once every four years. Through its cutting-edge research, Estée Lauder has been able to advance its understanding of the biology of skin aging, developing its exclusive and patented SIRTIVITY-LP™ technology, proven to not only slow, but help visibly reverse skin aging.
In January 2024, Estée Lauder will unveil its newest product innovation, new Re-Nutriv Ultimate Diamond Transformative Brilliance Soft Crème, with SIRTIVITY-LP™ which reveals visible age reversal starting in just 14 days.
Collaboration with the Stanford Center on Longevity
Building on the brand’s commitment to furthering longevity research, Estée Lauder announces its support of the Stanford Center on Longevity, a cross-disciplinary research center at Stanford University.
As the inaugural supporter of the Stanford Center on Longevity’s new Program on Aesthetics & Culture, Estée Lauder has made an initial three-year commitment to help fund a wide range of research activities, including New Map of Life post-doctoral fellowships and other work to advance the understanding of perceptions on longevity and vitality.
“We are thrilled to be collaborating with the Stanford Center on Longevity, a leading authority advancing longevity research,” said Boxford. “Through the support of their new Program of Aesthetics & Culture, our goal is to build the data-driven foundation from which to shape the future of aesthetics and extend skin healthspan.”
The Stanford Center on Longevity aims to accelerate and implement scientific discoveries, technological advances, behavioral practices, and social norms so that century-long lives are healthy and rewarding.
“We know that aging well involves feeling good about ourselves. Yet, little research has explored links between appearance and well-being,” said Laura L. Carstensen, Ph.D., Professor of Psychology; Fairleigh S. Dickinson Jr. Professor in Public Policy and the Director of the Stanford Center on Longevity. “Extended life expectancy offers us the opportunity to gain a deeper understanding about how people subjectively experience vitality and communicate this experience to others. We believe that skin, as the largest organ, plays a sizeable role in conveying this vitality. With support from with Estée Lauder, we look forward to further exploration of how physical appearance and visible skin health influences perceptions of aging.”
Estée Lauder Longevity Collective
Estée Lauder also announces the launch of its first-ever Longevity Collective, a curated group of influential experts and global pioneers in longevity science and lifestyle.
Beginning in January 2024, the Estée Lauder Longevity Collective will serve as a brand advisory board, bringing the latest insights, research findings, and resources to inform Estée Lauder’s ongoing approach to skin longevity research. Its members will also participate in events, media and content partnerships, as well as editorial on the brand’s new online content hub, the Longevity Collective will enable Estée Lauder to educate and drive conversation around healthspan versus lifespan and aging well.
In addition to lead Estée Lauder scientist, Dr. Nadine Pernodet, Senior Vice President, Bioscience, Global R&D, the Longevity Collective includes long-term Estée Lauder partner Dr. Danica Chen, Professor, Metabolic Biology, Nutritional Sciences & Toxicology, University of California Berkeley; Jennifer Garrison, Ph.D., Assistant Professor, Buck Institute for Research on Aging & Co-Founder & Director, Global Consortium for Reproductive Longevity & Equality; Dr. Mark Lachs, Irene and Roy Psaty Distinguished Professor of Medicine & Co-Director for the Center of Aging Research & Clinical Care at Weill Cornell Medicine; Dr. Zakia Rahman, Clinical Professor of Dermatology, Stanford University School of Medicine; Serena Liang Jing, New Map of Life Fellow, Stanford Center on Longevity and Michael Clinton, Founder & CEO, ROAR Forward. In addition, long-standing Estée Lauder Global Brand Ambassador, Carolyn Murphy, will serve as a member of the Longevity Collective, sharing her beauty, wellness, and lifestyle insights. Having worked with the Estée Lauder brand for more than two decades, Murphy is one of the industry’s longest-serving beauty ambassadors.
Aerin Lauder, Founder and Creative Director of AERIN, and Style & Design Director of Estée Lauder ReNutriv, said: “My grandmother, Estée, was a trailblazer. She was ahead of her time in every way and changed how we think about aging, confidence, and beauty. Today, the Estée Lauder brand continues to embody her pioneer spirit, and I think she would be incredibly excited to see her namesake brand leading the new skin longevity movement and inspiring consumers everywhere to live well at any age.”
About Estée Lauder
Estée Lauder is the flagship brand of The Estée Lauder Companies Inc. Founded by Estée Lauder, one of the world’s first female entrepreneurs, the brand today continues her legacy of creating the most innovative, sophisticated, high-performance skincare and makeup products and iconic fragrances – all infused with a deep understanding of women’s needs and desires. Today, Estée Lauder engages with women in over 150 countries around the world and at dozens of touch points – from in-store to digital. And each of these relationships consistently reflects Estée’s powerful and authentic point of view.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231214287961/en/
Contact information
Tara Connaughton, tconnaug@estee.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom